Checkmate Pharmaceuticals, Inc. – NASDAQ:CMPI
Checkmate Pharmaceuticals stock price today
$10.5
Market open
Closed in about 1 hour
Checkmate Pharmaceuticals stock price monthly change
+1.06%
month
Checkmate Pharmaceuticals stock price quarterly change
+268.42%
quarter
Checkmate Pharmaceuticals stock price yearly change
+57.19%
year
Checkmate Pharmaceuticals key metrics
Market Cap | N/A |
Enterprise value | N/A |
P/E | -3.84 |
EV/Sales | N/A |
EV/EBITDA | N/A |
Price/Sales | N/A |
Price/Book | 4.12 |
PEG ratio | 0.08 |
EPS | -2.92 |
Revenue | N/A |
EBITDA | -63.01M |
Income | -63.16M |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | 0% |
Oper. margin | 0% |
Gross margin | 0% |
EBIT margin | 0% |
EBITDA margin | N/A |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeCheckmate Pharmaceuticals stock price history
Checkmate Pharmaceuticals stock forecast
Checkmate Pharmaceuticals financial statements
| Jun 2021 | 0 | -18.97M | |
|---|---|---|---|
| Sep 2021 | 0 | -14.96M | |
| Dec 2021 | 0 | -13.34M | |
| Mar 2022 | 0 | -15.88M |
| 2021-08-12 | -0.94 | -0.88 |
|---|---|---|
| 2021-11-12 | -0.71 | -0.69 |
| 2022-03-29 | -0.74 | -0.62 |
| 2022-05-12 | -0.73 | -0.73 |
| Jun 2021 | 101681000 | 6.70M | 6.59% |
|---|---|---|---|
| Sep 2021 | 89339000 | 7.81M | 8.74% |
| Dec 2021 | 78838000 | 9.37M | 11.9% |
| Mar 2022 | 66944000 | 11.94M | 17.84% |
| Jun 2021 | -15.38M | 39.35M | 16K |
|---|---|---|---|
| Sep 2021 | -14.02M | 4.72M | -314K |
| Dec 2021 | -9.99M | 6.85M | 326K |
| Mar 2022 | -10.67M | -527K | 0 |
Checkmate Pharmaceuticals alternative data
| Aug 2023 | 30 |
|---|---|
| Sep 2023 | 30 |
| Oct 2023 | 30 |
| Nov 2023 | 30 |
| Dec 2023 | 30 |
| Jan 2024 | 30 |
| Feb 2024 | 30 |
| Mar 2024 | 30 |
| Apr 2024 | 30 |
| May 2024 | 30 |
| Jun 2024 | 30 |
| Jul 2024 | 30 |
Checkmate Pharmaceuticals other data
What is insider trading?
| Period | Buy | Sel |
|---|---|---|
| Jun 2021 | 10802 | 0 |
| Feb 2022 | 0 | 8110 |
| Apr 2022 | 0 | 867541 |
| May 2022 | 0 | 649903 |
| Patent |
|---|
Application Filling date: 23 Dec 2020 Issue date: 8 Jul 2021 |
Application Filling date: 12 Feb 2019 Issue date: 4 Feb 2021 |
Grant Filling date: 19 Apr 2019 Issue date: 2 Feb 2021 |
Application Filling date: 5 May 2020 Issue date: 10 Sep 2020 |
Grant Utility: Combination tumor immunotherapy Filling date: 22 Dec 2015 Issue date: 16 Jun 2020 |
Application Filling date: 19 Apr 2019 Issue date: 27 Feb 2020 |
-
What's the price of Checkmate Pharmaceuticals stock today?
One share of Checkmate Pharmaceuticals stock can currently be purchased for approximately $10.5.
-
When is Checkmate Pharmaceuticals's next earnings date?
Unfortunately, Checkmate Pharmaceuticals's (CMPI) next earnings date is currently unknown.
-
Does Checkmate Pharmaceuticals pay dividends?
No, Checkmate Pharmaceuticals does not pay dividends.
-
What is Checkmate Pharmaceuticals's stock symbol?
Checkmate Pharmaceuticals, Inc. is traded on the NASDAQ under the ticker symbol "CMPI".
-
What is Checkmate Pharmaceuticals's primary industry?
Company operates in the Healthcare sector and Biotechnology industry.
-
How do i buy shares of Checkmate Pharmaceuticals?
Shares of Checkmate Pharmaceuticals can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Checkmate Pharmaceuticals's key executives?
Checkmate Pharmaceuticals's management team includes the following people:
- Dr. James E. Wooldridge M.D. Chief Medical Officer(age: 59, pay: $536,320)
- Dr. Kleem Chaudhary Ph.D. Chief Bus. Officer(age: 49, pay: $482,100)
- Mr. Alan Fuhrman Interim Chief Executive Officer, Pres & Director(age: 68, pay: $55,000)
-
How many employees does Checkmate Pharmaceuticals have?
As Jul 2024, Checkmate Pharmaceuticals employs 30 workers.
-
When Checkmate Pharmaceuticals went public?
Checkmate Pharmaceuticals, Inc. is publicly traded company for more then 5 years since IPO on 7 Aug 2020.
-
What is Checkmate Pharmaceuticals's official website?
The official website for Checkmate Pharmaceuticals is checkmatepharma.com.
-
Where are Checkmate Pharmaceuticals's headquarters?
Checkmate Pharmaceuticals is headquartered at 245 Main Street, Cambridge, MA.
-
How can i contact Checkmate Pharmaceuticals?
Checkmate Pharmaceuticals's mailing address is 245 Main Street, Cambridge, MA and company can be reached via phone at +61 76823625.
Checkmate Pharmaceuticals company profile:
Checkmate Pharmaceuticals, Inc.
checkmatepharma.comExchange:
NASDAQ
Full time employees:
30
Industry:
Biotechnology
Sector:
Healthcare
Checkmate Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing novel therapeutics for the treatment of cancer. It develops CMP-001, which is in phase II clinical trial in combination with pembrolizumab to treat patients with PD-1 refractory melanoma; combination with nivolumab to treat patients with PD-1 naĂŻve neoadjuvant melanoma; and treatment in patients with PD-1 refractory melanoma. Checkmate Pharmaceuticals, Inc. has strategic alliances with Merck KGaA and Pfizer. The company was incorporated in 2015 and is headquartered in Cambridge, Massachusetts. As of May 27, 2022, Checkmate Pharmaceuticals, Inc. operates as a subsidiary of Regeneron Pharmaceuticals, Inc.
245 Main Street
Cambridge, MA 02142
Cambridge, MA 02142
CIK: 0001651431
ISIN: US1628181083
CUSIP: 162818108
